Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
Aug 2, 2012
PDF 10.2 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Complete Transfer of BELVIQ® (lorcaserin HCl) New Drug Application
Jul 30, 2012
PDF 12.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
Jul 11, 2012
PDF 11.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
Jul 9, 2012
PDF 9.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
Jul 5, 2012
PDF 11.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ® (lorcaserin HCl) for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
Jun 27, 2012
PDF 23.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
May 21, 2012
PDF 11.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Prices Public Offering of Common Stock
May 16, 2012
PDF 11.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 15, 2012
PDF 12.4 KB Add to Briefcase
View Summary Arena and Eisai Expand Marketing and Supply Agreement for Lorcaserin
May 10, 2012
PDF 15.5 KB Add to Briefcase
View Summary Lorcaserin Receives Positive Vote From FDA Advisory Committee
May 10, 2012
PDF 14.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
May 1, 2012
PDF 16.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces European Medicines Agency's Acceptance of Lorcaserin Marketing Authorization Application for Weight Control
Mar 26, 2012
PDF 11.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments
Mar 14, 2012
PDF 20.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14
Mar 8, 2012
PDF 10.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control
Mar 2, 2012
PDF 11.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference
Feb 23, 2012
PDF 10.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 8, 2012
PDF 10.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin
Feb 1, 2012
PDF 12.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces $33 Million Financing
Jan 11, 2012
PDF 7.5 KB Add to Briefcase
Showing 81-100 of 470 Page: 1 2 3 4 5 6 7 8 9 ... 24  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase